Literature DB >> 24571756

Clinical practice. Attention deficit-hyperactivity disorder in children and adolescents.

Heidi M Feldman1, Michael I Reiff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24571756     DOI: 10.1056/NEJMcp1307215

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  56 in total

1.  Prevalence rates of youths diagnosed with and medicated for ADHD in a nationwide survey in Taiwan from 2000 to 2011.

Authors:  L-J Wang; S-Y Lee; S-S Yuan; C-J Yang; K-C Yang; T-S Huang; W-J Chou; M-C Chou; M-J Lee; T-L Lee; Y-C Shyu
Journal:  Epidemiol Psychiatr Sci       Date:  2016-07-20       Impact factor: 6.892

2.  Using a Brief Parent-Report Measure to Track Outcomes for Children and Teens with ADHD.

Authors:  Alyssa McCarthy; Sunna Asghar; Timothy Wilens; Stephanie Romo; Hayley Kamin; Michael Jellinek; Michael Murphy
Journal:  Child Psychiatry Hum Dev       Date:  2016-06

3.  Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients.

Authors:  M Riera; X Castells; A Tobias; R Cunill; L Blanco; D Capellà
Journal:  Psychopharmacology (Berl)       Date:  2017-06-19       Impact factor: 4.530

4.  A Multimodal Intervention for Children with ADHD Reduces Inequity in Health and Education Outcomes.

Authors:  Jennifer E Enns; Jason R Randall; Mark Smith; Dan Chateau; Carole Taylor; Marni Brownell; James M Bolton; Elaine Burland; Alan Katz; Laurence Y Katz; Nathan C Nickel
Journal:  Can J Psychiatry       Date:  2017-02-01       Impact factor: 4.356

5.  Methylphenidate and atomoxetine inhibit social play behavior through prefrontal and subcortical limbic mechanisms in rats.

Authors:  E J Marijke Achterberg; Linda W M van Kerkhof; Ruth Damsteegt; Viviana Trezza; Louk J M J Vanderschuren
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

Review 6.  Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

Authors:  Jochen Antel; Özgür Albayrak; Gerd Heusch; Tobias Banaschewski; Johannes Hebebrand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-23       Impact factor: 5.270

7.  Transcranial direct current stimulation improves clinical symptoms in adolescents with attention deficit hyperactivity disorder.

Authors:  Cornelia Soff; Anna Sotnikova; Hanna Christiansen; Katja Becker; Michael Siniatchkin
Journal:  J Neural Transm (Vienna)       Date:  2016-11-16       Impact factor: 3.575

Review 8.  New Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and Tolerability.

Authors:  Samuele Cortese; Giulia D'Acunto; Eric Konofal; Gabriele Masi; Benedetto Vitiello
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

9.  Prenatal alcohol use as a risk for attention-deficit/hyperactivity disorder.

Authors:  Daniel Pagnin; Maria Luiza Zamboni Grecco; Erikson Felipe Furtado
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-10-23       Impact factor: 5.270

Review 10.  Who says this is a modern disorder? The early history of attention deficit hyperactivity disorder.

Authors:  Jose Martinez-Badía; Jose Martinez-Raga
Journal:  World J Psychiatry       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.